AnimalBiome, an Oakland, Calif.-based, science-powered animal health company, raised $8.6m in Series A funding.
The round was led by Cargill. Additional investors include SOSV (IndieBio) along with Moai Capital, Digitalis Ventures, Michelson Found Animal Foundation, and R/GA Ventures.
The company intends to use the funds to accelerate growth and create new microbial cocktails for companion animals.
Led by Carlton Osborne, co-founder and CEO, and Holly Ganz, co-founder and Chief Science Officer, AnimalBiome uses science to access, restore, and maintain the gut health of cats and dogs. Founded in 2016 by researchers at UC Davis and UC Berkeley, the company has launched DTC microbiome testing in pets and uses genetic sequencing to characterize the microbiomes of individual pets. Using an algorithm created from its proprietary reference database, the results are provided to both veterinarians and pet parents in an actionable report allowing them to make personalized changes in diet, including prebiotics, macronutrient ratios, and other supplements to restore balance to the gut microbiome. The company also uses its proprietary pet microbiome platform to design new supplements to manipulate and support healthy microbiomes.
The investment enables the company to create new microbial cocktails for cats and dogs with chronic digestive disorders and skin conditions.